The pronounced therapeutic effect of UA is diminished by over-expressed P62 or TNF-α administration, suggesting that UA alleviates podocyte injuries through the P62-NF-κB-MDM2 axis in DN conditions. The gene discussed is SQSTM1; the disease is liver dysplastic nodule.